Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

Published: 28 February 2025| Version 1 | DOI: 10.17632/d9ngfbjxp3.1
Contributors:
, Song Park,
,
,

Description

Supplemental figure 1 relative survival by year of diagnosis and extent of MCC at presentation. Supplemental figure 2 24-month overall survival by year of diagnosis and extent of Merkel cell carcinoma at presentation.

Files

Institutions

  • University of Washington
  • Swedish Cancer Institute
  • Fred Hutchinson Cancer Research Center
  • Washington State University

Categories

Epidemiology, Oncology, Merkel Cell Carcinoma, Survival Analysis, Immunotherapy, Database

Funders

Licence